{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T10:22:21Z","timestamp":1782382941403,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.pnpbp.2006.04.015","type":"journal-article","created":{"date-parts":[[2006,6,6]],"date-time":"2006-06-06T22:55:54Z","timestamp":1149634554000},"page":"1109-1116","source":"Crossref","is-referenced-by-count":15,"title":["Psychotropic drug prescription in a psychiatric university hospital in Germany"],"prefix":"10.1016","volume":"30","author":[{"given":"Eugen","family":"Davids","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Specka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Gastpar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2006.04.015_bib1","first-page":"S1","article-title":"Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association","volume":"158","author":"American Psychiatric Association Practice Guidelines","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib2","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2174\/1381612043384033","article-title":"Antipsychotic polypharmacy","volume":"10","author":"Ananth","year":"2004","journal-title":"Curr Pharm Res"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4088\/JCP.v66n0109","article-title":"A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety","volume":"66","author":"Anil Yagcioglu","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1055\/s-2002-36394","article-title":"Prescribing second-generation antipsychotics and the evolving standard care in Italy","volume":"35","author":"Barbui","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib5","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1176\/appi.ajp.159.11.1932","article-title":"Inpatient antipsychotic drug use in 1998, 1993, and 1989","volume":"159","author":"Centorrino","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib6","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1176\/appi.ajp.161.4.700","article-title":"Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits","volume":"161","author":"Centorrino","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/hup.700","article-title":"Antipsychotic drug use: McLean Hospital, 2002","volume":"20","author":"Centorrino","year":"2005","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/oxfordjournals.schbul.a006920","article-title":"Antipsychotic prescribing practices in Connecticut's public mental health system: rates of changing medications and prescribing styles","volume":"28","author":"Covell","year":"2002","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib9","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1055\/s-2004-815506","article-title":"Research methods in drug surveillance","volume":"37","author":"Engel","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib10","first-page":"S20","article-title":"Pharmacological and pharmacokinetic considerations in choosing an antipsychotic","volume":"60","author":"Ereshefsky","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4088\/JCP.v61n0104","article-title":"The increasing use of polypharmacotherapy for refractory mood disorders: 22\u00a0years of study","volume":"61","author":"Frye","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib12","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.4088\/JCP.v65n1013","article-title":"Prevalence, trends, and factors associated with antipsychotic polypharmacy among medicaid-eligible schizophrenia patients 1998\u20132000","volume":"65","author":"Ganguly","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib13","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1055\/s-2004-815505","article-title":"The AMSP drug safety programme: methods and global results","volume":"37","author":"Grohmann","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib14","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1055\/s-2004-815508","article-title":"Psychotropic drug use in psychiatric inpatients: recent trends and changes over time-data from the AMSP study","volume":"37","author":"Grohmann","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-2005-837767","article-title":"Emerging evidence for the use of atypical antipsychotics in borderline personality disorder","volume":"38","author":"Grootens","year":"2005","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00004850-200307000-00006","article-title":"Antipsychotic prescribing patterns in Germany: a retrospective analysis using a large outpatient prescription database","volume":"18","author":"Hamann","year":"2003","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib17","series-title":"ICD-10, Kapitel V (F), Weltgesundheitsorganisation","author":"Internationale Klassifikation psychischer St\u00f6rungen","year":"1991"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1176\/appi.ajp.162.1.130","article-title":"Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial","volume":"162","author":"Josiassen","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib19","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1176\/appi.ajp.159.9.1534","article-title":"From conventional to atypical antipsychotics and back: dynamic processes in the diffusion of new medications","volume":"159","author":"Leslie","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1034\/j.1399-5618.2000.020205.x","article-title":"Psychotropic drug prescription patterns among patients with bipolar I disorder","volume":"2","author":"Levine","year":"2000","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(04)16770-6","article-title":"Borderline personality disorder","volume":"364","author":"Lieb","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1521\/pedi.18.1.90.32768","article-title":"Recent trends in the pharmacotherapy of personality disorders","volume":"18","author":"Markovitz","year":"2004","journal-title":"J Personal Disord"},{"issue":"Suppl. 11","key":"10.1016\/j.pnpbp.2006.04.015_bib23","first-page":"153","article-title":"Rational polypharmacy in the bipolar affective disorders","author":"Post","year":"1996","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-2004-815469","article-title":"Patterns of antipsychotic utilization in a tertiary care psychiatric institution","volume":"37","author":"Procyshyn","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/10401239309148969","article-title":"Rational polypharmacy in the treatment of mood disorders","volume":"5","author":"Reus","year":"1993","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0924-9338(99)80713-5","article-title":"Polypharmacy in psychiatric treatment. Patterns of psychotropic drug use in Austrian psychiatric clinics","volume":"14","author":"Rittmannsberger","year":"1999","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib27","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1055\/s-2001-15305","article-title":"Symptom-focussed drug therapy in borderline personality disorder","volume":"69","author":"Schmahl","year":"2001","journal-title":"Fortschr Neurol Psychiatr"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib28","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/0010-440X(84)90037-3","article-title":"Polypharmacy in psychiatric practice","volume":"25","author":"Schussler","year":"1984","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4088\/JCP.v60n0701","article-title":"Antipsychotic polypharmacy: Part 1. therapeutic option or dirty little secret?","volume":"60","author":"Stahl","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1034\/j.1600-0447.2002.2e011.x","article-title":"Antipsychotic polypharmacy: evidence based or eminence based","volume":"106","author":"Stahl","year":"2002","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1055\/s-2007-979185","article-title":"Psychotropic drug prescription in a psychiatric university hospital","volume":"32","author":"Voirol","year":"1999","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib32","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.4088\/JCP.v65n0812","article-title":"Switching antipsychotics in inpatient schizophrenia care: predictors and outcomes","volume":"65","author":"Weinmann","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11920-004-0041-9","article-title":"Update on pharmacotherapy of borderline personality disorder","volume":"6","author":"Zanarini","year":"2004","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.pnpbp.2006.04.015_bib34","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1007\/s00115-005-1887-8","article-title":"Augmenting atypical antipsychotic medications with clozapine","volume":"76","author":"Zink","year":"2005","journal-title":"Nervenarzt"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606001734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606001734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T21:54:27Z","timestamp":1547589267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584606001734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0278584606001734"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2006.04.015","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}